Patterson S - Search Results

1

Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.

Park J, Chen L, Shade K, Lazarus P, Seigne J, Patterson S, Helal M, Pow-Sang J. Park J, et al. Among authors: patterson s. J Urol. 2004 Jun;171(6 Pt 1):2484-8. doi: 10.1097/01.ju.0000117748.44313.43. J Urol. 2004. PMID: 15126881

2

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.

Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, Pow-Sang J. Park J, et al. Among authors: patterson s. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1473-8. doi: 10.1158/1055-9965.EPI-06-0141. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896035

3

Controversies surrounding androgen deprivation for prostate cancer.

Patterson SG, Balducci L, Pow-Sang JM. Patterson SG, et al. Cancer Control. 2002 Jul-Aug;9(4):315-25. doi: 10.1177/107327480200900406. Cancer Control. 2002. PMID: 12228757 Free article. Review.

4

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.

Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B, Pow-Sang J, Yeatman T, Djeu JY. Patterson SG, et al. Oncogene. 2006 Oct 5;25(45):6113-22. doi: 10.1038/sj.onc.1209632. Epub 2006 May 1. Oncogene. 2006. PMID: 16652143

5

Management of androgen-independent prostate cancer.

Diaz M, Patterson SG. Diaz M, et al. Cancer Control. 2004 Nov-Dec;11(6):364-73. doi: 10.1177/107327480401100604. Cancer Control. 2004. PMID: 15625524 Free article. Review.

6

Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison.

Jim HS, Small BJ, Patterson S, Salup R, Jacobsen PB. Jim HS, et al. Among authors: patterson s. Support Care Cancer. 2010 Jan;18(1):21-7. doi: 10.1007/s00520-009-0625-3. Epub 2009 Apr 3. Support Care Cancer. 2010. PMID: 19343369 Free PMC article.

7

Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.

Ulloa EW, Salup R, Patterson SG, Jacobsen PB. Ulloa EW, et al. Psychooncology. 2009 Jun;18(6):598-605. doi: 10.1002/pon.1427. Psychooncology. 2009. PMID: 18942660

8

Management of hot flashes in men with prostate cancer being treated with androgen deprivation therapy.

Alekshun TJ, Patterson SG. Alekshun TJ, et al. Support Cancer Ther. 2006 Oct 1;4(1):30-7. doi: 10.3816/SCT.2006.n.029. Support Cancer Ther. 2006. PMID: 18632464

9

The Book of Job: a 2,500-year-old current guide to the practice of oncology: the nexus of medicine and spirituality.

Patterson S, Balducci L, Meyer R. Patterson S, et al. J Cancer Educ. 2002 Winter;17(4):237-40. doi: 10.1080/08858190209528845. J Cancer Educ. 2002. PMID: 12556063

10

Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome.

Ho VQ, Wetzstein GA, Patterson SG, Bradbury R. Ho VQ, et al. Support Cancer Ther. 2006 Apr 1;3(3):178-82. doi: 10.3816/SCT.2006.n.016. Support Cancer Ther. 2006. PMID: 18632493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,409 results

Search Page